Spot Trading’s Edwards Lifesciences EW Stock Holding History

Spot Trading’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.07M	Buy	29,400 +2,100	+8%	+$80.1K	0.02%	1113
2017 Q2	$1.08M	Buy	+27,300	New	+$996K	0.02%	1046
2016 Q2	–	Sell	-21,000	Closed	-$617K	–	3450
2016 Q1	$617K	Sell	21,000 -7,200	-26%	-$199K	0.01%	1424
2015 Q4	$742K	Buy	+28,200	New	+$732K	0.01%	1659
2015 Q3	–	Sell	-600	Closed	-$14K	–	4011
2015 Q2	$14K	Buy	+600	New	+$13.5K	﹤0.01%	3515
2015 Q1	–	Sell	-13,800	Closed	-$293K	–	3997
2014 Q4	$293K	Buy	13,800 +7,800	+130%	+$157K	﹤0.01%	2695
2014 Q3	$102K	Sell	6,000 -23,400	-80%	-$369K	﹤0.01%	3507
2014 Q2	$421K	Buy	29,400 +3,600	+14%	+$48.8K	﹤0.01%	2824
2014 Q1	$319K	Sell	25,800 -316,200	-92%	-$3.65M	﹤0.01%	2868
2013 Q4	$3.75M	Buy	342,000 +321,600	+1,576%	+$3.63M	0.02%	1073
2013 Q3	$237K	Buy	+20,400	New	+$239K	﹤0.01%	2898

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Spot Trading's EW Position: Q3 2017 in Review

Spot Trading reduced its Edwards Lifesciences (EW) stake by 52% in Q3 2017, selling an estimated $163K and leaving 3,954 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2403.

Spot Trading first reported a position in EW in Q3 2013 and has held it in 13 quarters since. The position peaked at $1.7M in Q1 2016. 739 funds tracked by Wall St. Rank hold EW as of Q3 2017.

Spot Trading held 3,954 shares of Edwards Lifesciences worth $144K as of Q3 2017.
Spot Trading sold 4,284 Edwards Lifesciences shares in Q3 2017, an estimated $163K.
Edwards Lifesciences made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2403 holding.
Spot Trading first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 13 quarters since.
Spot Trading's Edwards Lifesciences position peaked at $1.7M in Q1 2016.
739 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.